menu
    • menu

    Company profile for MedRx

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MedRx is a pharmaceutical company that develops pharmaceutical drugs based on the transdermal absorption system in Japan. It develops medicines based on Ionic Liquid Transdermal System. The company’s products in the pipeline include MRX-4TZT; MRX-5LBT; MRX-10XT; and MRX-5DML. It also offers microneedle patch for delivery of vaccines and/orAPIs through the skin. MedRx Co., Ltd. was founded in 2002 and is headquartered in Higa...
    MedRx is a pharmaceutical company that develops pharmaceutical drugs based on the transdermal absorption system in Japan. It develops medicines based on Ionic Liquid Transdermal System. The company’s products in the pipeline include MRX-4TZT; MRX-5LBT; MRX-10XT; and MRX-5DML. It also offers microneedle patch for delivery of vaccines and/orAPIs through the skin. MedRx Co., Ltd. was founded in 2002 and is headquartered in Higashikagawa, Japan.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MedRxjapan Flag
    Country
    Country
    Japan
    Address
    Address
    431-7 Nishiyama Higashikagawa-city, Kagawa
    Telephone
    Telephone
    +81-879-23-3071
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.medrx.co.jp/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    International Sweetener Colloquium

    Not Confirmed

    envelop Contact Supplier

    International Sweetener Colloquium

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ultimovacs Publishes Phase II FOCUS Trial Results on medRxiv
    Ultimovacs Publishes Phase II FOCUS Trial Results on medRxiv

    25 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/25/2969541/0/en/Ultimovacs-Announces-Publication-of-Phase-II-FOCUS-Trial-Results-on-medRxiv.html

    GLOBENEWSWIRE
    25 Oct 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search